ArticleAmerican journal of cancer research2025

Potential benefits of combined treatment with Hsp90 inhibitor AUY922 and cisplatin for overcoming drug resistance in nasopharyngeal carcinoma.

William C Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.